VRDN-001, A Potent and Selective Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist Antibody for Thyroid Eye Disease (TED): Interim Phase 1 Safety and Pharmacodynamic Results in Healthy Volunteers. American Thyroid Association Annual Meeting October 2022.

Viridian-ATA-2022-Poster-001-568